Cypress Capital Group’s Bausch Health BHC Stock Holding History

Cypress Capital Group’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-3,000	Closed	-$305K	–	166
2015 Q4	$305K	Sell	3,000 -533	-15%	-$59.9K	0.07%	162
2015 Q3	$630K	Hold	3,533	–	–	0.16%	114
2015 Q2	$785K	Hold	3,533	–	–	0.18%	107
2015 Q1	$702K	Hold	3,533	–	–	0.16%	113
2014 Q4	$506K	Hold	3,533	–	–	0.12%	136
2014 Q3	$464K	Hold	3,533	–	–	0.11%	133
2014 Q2	$446K	Hold	3,533	–	–	0.1%	140
2014 Q1	$466K	Hold	3,533	–	–	0.11%	126
2013 Q4	$415K	Hold	3,533	–	–	0.1%	135
2013 Q3	$369K	Hold	3,533	–	–	0.09%	141
2013 Q2	$304K	Buy	+3,533	New	+$278K	0.06%	166

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Cypress Capital Group's BHC Position: Q1 2016 in Review

Cypress Capital Group sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 3,000 shares — an estimated $305K sold.

Cypress Capital Group first reported a position in BHC in Q2 2013 and held it in 11 quarters. The position peaked at $785K in Q2 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Cypress Capital Group reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Cypress Capital Group sold 3,000 Bausch Health shares in Q1 2016, an estimated $305K.
Cypress Capital Group first reported a position in Bausch Health in Q2 2013 and held it in 11 quarters.
Cypress Capital Group's Bausch Health position peaked at $785K in Q2 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Cypress Capital Group's 13F filing for Q1 2016, filed 17 May 2016.